Videos

Sponsored

Videos

Targeting HER2 in Metastatic Colorectal Cancer: Emerging and Future Options

08/04/2023

In this symposium, experts discuss the molecular basis for HER2-targeted therapy for patients with HER2-positive colorectal cancer, the diagnostic approach for HER2-amplified metastatic colorectal cancer, and the ongoing journey of precision...

In this symposium, experts...

08/04/2023

Oncology

Bradley Monk, MD, University of Arizona School of Medicine

Videos

Mirvetuximab Soravtansine for Folate Receptor-Alpha High, Platinum-Resistant Ovarian Cancer

08/02/2023

Featuring Bradley J. Monk, MD

Bradley Monk, MD, discusses the results from the phase 3 MIRASOL trial and shares insights about mirvetuximab soravtansine for folate receptor-alpha high, platinum-resistant ovarian cancer.

Bradley Monk, MD, discusses the...

08/02/2023

Oncology

Maximilian Kloft, MD, Maastricht University

Videos

Relationship Between Tumor Infiltrating Immune Cells And Tumor Draining Lymph Nodes Among Patients With Esophageal Cancer

08/01/2023

Featuring Maximilian Kloft, MD

Featuring Maximilian Kloft, MD ...

At the 2023 World Congress on Gastrointestinal Cancers, Maximilian Kloft, MD, presented results from a study relating the tumor infiltrating lymphocytes and the tumor-draining lymph nodes in esophageal cancer.

At the 2023 World Congress on...

08/01/2023

Oncology

Kristen Ciombor, MD, Vanderbilt-Ingram Cancer Center

Videos

Checkpoint Inhibition for Patients With Colorectal Cancer and High Microsatellite Instability

08/01/2023

Featuring Kristen Ciombor, MD

At the 2023 World Congress on Gastrointestinal Cancers, Kristen Ciombor, MD, discussed the opportunities for checkpoint inhibition among patients with colorectal cancer and high microsatellite instability.

At the 2023 World Congress on...

08/01/2023

Oncology

Philip Philip, MD, Wayne State University

Videos

Next-Generation Sequencing for All Patients With Pancreatic Ductal Adenocarcinoma

08/01/2023

Featuring Philip Philip, MD

At the 2023 World Congress on Gastrointestinal Cancers, Philip Philip, MD, argued for doing next-generation sequencing for all patients with pancreatic ductal adenocarcinoma.

At the 2023 World Congress on...

08/01/2023

Oncology

Yu Sunakawa, MD, St. Marianna University School of Medicine

Videos

Modified FOLFOXIRI Plus Cetuximab as the First-Line Treatment for Patients With RAS Wild-Type Metastatic Colorectal Cancer

07/28/2023

Featuring Yu Sunakawa, MD

At the 2023 ESMO World Congress on Gastrointestinal Cancers, Yu Sunakawa, MD, presented updated survival data from the phase 2 DEEPER trial, evaluating modified(m)-FOLFOXIRI plus cetuximab vs m-FOLFOXIRI plus bevacizumab among patients with...

At the 2023 ESMO World Congress...

07/28/2023

Oncology

Federica Marmorino, MD, University of Pisa

Videos

Effect of Gut Microbiome Composition on Atezolizumab Efficacy Among Patients With Colorectal Cancer

07/28/2023

Featuring Federica Marmorino, MD

Featuring Federica Marmorino, MD ...

At the 2023 World Congress on Gastrointestinal Cancers, Federica Marmorino, MD, discusses the effect the gut microbiome composition may have on the efficacy of checkpoint inhibitors like atezolizumab for colorectal cancer.

At the 2023 World Congress on...

07/28/2023

Oncology

Kathleen Moore, MD, Stephenson Cancer Center

Videos

Mirvetuximab Soravtansine Improved Overall Survival for Patients With Folate Receptor Alpha-High Platinum-Resistant Ovarian Cancer

07/27/2023

At the 2023 ASCO Annual Meeting, Kathleen Moore, MD, shares results from the MIRASOL trial, evaluating mirvetuximab soravtansine among patients with folate recetor alpha-high platinum-resistant ovarian cancer.

At the 2023 ASCO Annual Meeting,...

07/27/2023

Oncology

Videos

Epcoritamab Plus Rituximab and Lenalidomide Regimen Demonstrates High Response Rates Among Patients With High-Risk Follicular Lymphoma

07/19/2023

Featuring Reid Merryman, MD

At the 2023 ASCO meeting, Reid Merryman, MD, shares data assessing the efficacy and safety of epcoritamab plus rituximab and lenalidomide among patients with R/R FL.

At the 2023 ASCO meeting, Reid...

07/19/2023

Oncology

Eileen O'Reilly, MD, Memorial Sloan Kettering Cancer Center

Videos

Current Standards and Emerging Options for Pancreatic Cancer

07/18/2023

Featuring Eileen O'Reilly, MD

At the 2023 World Congress on Gastrointestinal Cancers, Eileen O’Reilly, MD, discusses the existing standards and upcoming options for the treatment of pancreatic cancer.

At the 2023 World Congress on...

07/18/2023

Oncology

Videos

Specialties

Specialties

Events

Year Round Education

HMP Global Products